For instance, genetic Hif1α ablation in myeloid cells protects against the development of HFD-induced metabolic inflammation and insulin resistance [57–59], while macrophage HIF2α suppresses inflammation and alleviates obesity-related insulin resistance [60, 61]. This evidence concerns the gene EPAS1 and Insulin resistance.